Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
114,331,829
-
Total 13F shares
-
18,349,000
-
Share change
-
+335,416
-
Total reported value
-
$97,801,000
-
Price per share
-
$5.33
-
Number of holders
-
41
-
Value change
-
+$1,769,404
-
Number of buys
-
25
-
Number of sells
-
12
Institutional Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q3 2015
As of 30 Sep 2015,
FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) was held by
41 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,349,000 shares.
The largest 10 holders included
FMR LLC, Polaris Venture Management Co. V, L.L.C., KINGDON CAPITAL MANAGEMENT, L.L.C., Redmile Group, LLC, WELLINGTON MANAGEMENT GROUP LLP, Broadfin Capital, LLC, ORBIMED ADVISORS LLC, HIGHLAND CAPITAL MANAGEMENT LP, FRANKLIN RESOURCES INC, and VANGUARD GROUP INC.
This page lists
41
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.